Insider Information & Trading
We protect insider information and prevent insider trading
Insider information is defined as non-public information about Roche or its business partners which a reasonable investor would consider important in deciding whether to buy or sell the company’s securities. Such information includes for example financial results and information about possible mergers, acquisitions or divestures, capital increases, capital market transactions, important licensing agreements and other collaborations as well as results from major clinical trials.
Roche employees who learn about insider information in the performance of their duties, whether intentionally or by coincidence, are considered insiders. Likewise, non-employees who obtain such insider information can also be considered as insiders.
Insiders must comply with the following rules:
- Insider information must be kept strictly confidential and may not be disclosed to any non-insider within or outside Roche, including family members;
- Insiders must not buy, sell or otherwise trade in securities of Roche or any other listed companies involved;
- Insiders must not provide trading recommendations to non-insiders.
In most countries insider trading is strictly illegal and the acting insider him-/herself as well as Roche may be penalised.
Roche complies with applicable insider trading laws and regulations and has established rules to protect insider information and prevent insider trading.